Ami Asset Management Upped By $8.41 Million Its West Pharmaceutcl Svcs Com (WST) Position; Hahn Capital Management Increased Its Cbre Group (CBG) Stake

Hahn Capital Management Llc increased Cbre Group (CBG) stake by 0.96% reported in 2017Q3 SEC filing. Hahn Capital Management Llc acquired 11,091 shares as Cbre Group (CBG)’s stock declined 5.61%. The Hahn Capital Management Llc holds 1.17M shares with $44.35B value, up from 1.16M last quarter. Cbre Group now has $15.30 billion valuation. The stock decreased 0.33% or $0.15 during the last trading session, reaching $45.73. About 1.30M shares traded. CBRE Group, Inc. (NYSE:CBG) has risen 21.33% since January 23, 2017 and is uptrending. It has outperformed by 4.63% the S&P500.

Ami Asset Management Corp increased West Pharmaceutcl Svcs Com (WST) stake by 35.23% reported in 2017Q3 SEC filing. Ami Asset Management Corp acquired 87,568 shares as West Pharmaceutcl Svcs Com (WST)’s stock rose 14.65%. The Ami Asset Management Corp holds 336,102 shares with $32.35M value, up from 248,534 last quarter. West Pharmaceutcl Svcs Com now has $7.45B valuation. The stock decreased 0.33% or $0.33 during the last trading session, reaching $100.28. About 207,035 shares traded. West Pharmaceutical Services, Inc. (NYSE:WST) has risen 33.75% since January 23, 2017 and is uptrending. It has outperformed by 17.05% the S&P500.

Among 5 analysts covering West Pharmaceutical Services (NYSE:WST), 3 have Buy rating, 0 Sell and 2 Hold. Therefore 60% are positive. West Pharmaceutical Services has $115 highest and $69 lowest target. $98.60’s average target is -1.68% below currents $100.28 stock price. West Pharmaceutical Services had 13 analyst reports since August 4, 2015 according to SRatingsIntel. The firm has “Hold” rating by Jefferies given on Tuesday, June 6. As per Wednesday, September 21, the company rating was downgraded by Wells Fargo. Janney Capital initiated West Pharmaceutical Services, Inc. (NYSE:WST) rating on Friday, January 8. Janney Capital has “Buy” rating and $69 target. The rating was maintained by Jefferies with “Hold” on Thursday, July 27. The firm has “Hold” rating by Bank of America given on Tuesday, October 17. The firm earned “Hold” rating on Monday, September 11 by Jefferies. The rating was maintained by Jefferies on Thursday, June 29 with “Hold”. On Tuesday, March 22 the stock rating was initiated by Wells Fargo with “Outperform”. The stock of West Pharmaceutical Services, Inc. (NYSE:WST) earned “Buy” rating by Jefferies on Friday, September 15. Zacks downgraded West Pharmaceutical Services, Inc. (NYSE:WST) on Tuesday, August 4 to “Hold” rating.

Since December 8, 2017, it had 0 insider purchases, and 1 sale for $2.08 million activity. FEDERICI WILLIAM J had sold 21,000 shares worth $2.08 million.

Investors sentiment decreased to 1.33 in Q3 2017. Its down 0.28, from 1.61 in 2017Q2. It is negative, as 31 investors sold WST shares while 76 reduced holdings. 42 funds opened positions while 100 raised stakes. 68.09 million shares or 1.49% more from 67.09 million shares in 2017Q2 were reported. Barclays Plc invested in 0% or 946 shares. Profund Advsrs Limited Liability Company reported 10,189 shares stake. Ubs Asset Mgmt Americas reported 0.01% stake. Wellington Shields And Co Ltd Company owns 4,000 shares for 0.13% of their portfolio. Riverbridge Ptnrs Ltd Liability Com accumulated 521,804 shares. Ami Asset Corp invested 2.29% of its portfolio in West Pharmaceutical Services, Inc. (NYSE:WST). Thompson Rubinstein Mgmt Or has 4,000 shares. Moreover, Oakbrook Invests Ltd Liability has 0.03% invested in West Pharmaceutical Services, Inc. (NYSE:WST) for 5,400 shares. Weaver C Barksdale Associate Inc has 88 shares for 0.01% of their portfolio. Blackrock Inc holds 5.89M shares or 0.03% of its portfolio. Los Angeles Management And Equity Rech invested in 0.07% or 119,714 shares. Smithfield Trust Co reported 1,200 shares. Citadel Advsr Llc reported 4,643 shares. Arrowstreet Capital Partnership reported 3,800 shares. Thrivent For Lutherans invested in 0.05% or 137,218 shares.

Since August 4, 2017, it had 0 insider purchases, and 10 selling transactions for $206.75 million activity. $113,005 worth of CBRE Group, Inc. (NYSE:CBG) was sold by Midler Laurence H on Friday, September 8. ValueAct Holdings – L.P. had sold 5.50M shares worth $197.45M. The insider MALEK FREDERIC V sold $298,644. $991,734 worth of CBRE Group, Inc. (NYSE:CBG) was sold by LAFITTE MICHAEL J on Tuesday, August 22. Shares for $1.00 million were sold by Frese Calvin W Jr. 20,000 CBRE Group, Inc. (NYSE:CBG) shares with value of $866,400 were sold by KIRK J. CHRISTOPHER. Borok Gil sold 25,627 shares worth $956,761.